Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Invesco Variable Rate Preferred ETF
VRP
$2.98B
| $6.46M | 0.01% |
264,159
+100,908
| +62% | +$2.43M |
|
1352
Kamada
KMDA
$412M
| $6.45M | 0.01% |
832,005
+23,700
| +3% | +$161K |
|
1353
First Financial Corp
THFF
$958M
| $6.44M | 0.01% |
118,773
+26,400
| +29% | +$1.31M |
|
1354
iShares Silver Trust
SLV
$28B
| $6.43M | 0.01% |
196,000
+117,200
| +149% | +$3.58M |
|
1355
Puma Biotechnology
PBYI
$404M
| $6.43M | 0.01% |
1,874,713
+45,500
| +2% | +$145K |
|
1356
Encompass Health
EHC
$11B
| $6.43M | 0.01% |
52,400
+1,500
| +3% | +$171K |
|
1357
Jones Lang LaSalle
JLL
$16.3B
| $6.42M | 0.01% |
25,089
+4,300
| +21% | +$986K |
|
1358
Bridgewater Bancshares
BWB
$571M
| $6.42M | 0.01% |
403,247
+52,500
| +15% | +$769K |
|
1359
Mesa Laboratories
MLAB
$564M
| $6.41M | 0.01% |
68,027
+59,827
| +730% | +$6.57M |
|
1360
Kewaunee Scientific
KEQU
$102M
| $6.4M | 0.01% |
109,011
+10,800
| +11% | +$401K |
|
1361
Murphy Oil
MUR
$5.7B
| $6.4M | 0.01% |
284,309
-3,091
| -1% | -$68.9K |
|
1362
Shore Bancshares
SHBI
$819M
| $6.39M | 0.01% |
406,315
+10,300
| +3% | +$145K |
|
1363
Nektar Therapeutics
NKTR
$2.39B
| $6.38M | 0.01% |
247,060
-66,392
| -21% | -$745K |
|
1364
Tandem Diabetes Care
TNDM
$1.34B
| $6.38M | 0.01% |
342,327
+56,200
| +20% | +$1.11M |
|
|
LINE
1365
Lineage Inc
LINE
$9.65B
| $6.38M | 0.01% |
146,569
-252,631
| -63% | -$12.2M |
|
1366
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.06B
| $6.37M | 0.01% |
124,000
+104,200
| +526% | +$5.32M |
|
1367
Simmons First National
SFNC
$3.41B
| $6.35M | 0.01% |
335,005
+62,848
| +23% | +$1.18M |
|
1368
Intellia Therapeutics
NTLA
$1.49B
| $6.35M | 0.01% |
+676,900
| New | +$5.56M |
|
1369
Federal Signal
FSS
$7.63B
| $6.34M | 0.01% |
59,600
-21,200
| -26% | -$1.89M |
|
1370
VanEck Gold Miners ETF
GDX
$22.7B
| $6.31M | 0.01% |
121,300
+28,800
| +31% | +$1.43M |
|
|
CIO
1371
DELISTED
City Office REIT
CIO
| $6.31M | 0.01% |
1,182,415
-73,600
| -6% | -$369K |
|
1372
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $6.31M | 0.01% |
131,890
+101,490
| +334% | +$4.81M |
|
1373
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.05B
| $6.31M | 0.01% |
141,200
+87,319
| +162% | +$3.88M |
|
1374
US Physical Therapy
USPH
$1.2B
| $6.29M | 0.01% |
80,423
-4,900
| -6% | -$361K |
|
1375
Ally Financial
ALLY
$13.2B
| $6.29M | 0.01% |
+161,400
| New | +$5.59M |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.